VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML

QR Code

VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML

Objective: Venetoclax-based regimens have emerged as a standard therapeutic option for newly diagnosed Acute Myeloid Leukemia (AML) in patients deemed unfit for intensive chemotherapy. However, the efficacy of venetoclax in fit patients remains an area of ongoing investigation. Notably, in specific...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dmitrii Zhogolev, Nikita Pastukhov, Bella Aybova, Anna Smirnova, Ivan Moiseev, Sergey Bondarenko, Alexander Kulagin
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137925001440
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine
by: Lin-Pierre Zhao, et al.
Published: (2025-07-01)

Targeted therapy of newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. A single-center ambispective cohort study
by: N. K. Pastukhov, et al.
Published: (2025-03-01)

PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
by: Kotoko Yamatani, et al.
Published: (2025-08-01)

Targeting HASPIN kinase disrupts SR protein–mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
by: Mengdan Liu, et al.
Published: (2025-08-01)

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “Rete Ematologica Pugliese” (REP)
by: M. Dargenio, et al.
Published: (2025-01-01)

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML
by: Anita J. Kumar, et al.
Published: (2018-06-01)

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia
by: Yiming Cai, et al.
Published: (2025-07-01)

Identification of the CBF Gene Family in Wheat and <i>TaCBF14B</i> Could Enhance the Drought Tolerance of <i>Arabidopsis thaliana</i>
by: Zubaidai Abudukerimu, et al.
Published: (2025-05-01)

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong
by: Qiwen Fang, et al.
Published: (2025-07-01)

The MdHB7L–MdICE1L–MdHOS1 Module Fine‐Tunes Apple Cold Response via CBF‐Dependent and CBF‐Independent Pathways
by: Jie Yang, et al.
Published: (2025-07-01)

Ocular Surface Status in Newly Diagnosed Glaucoma Cases
by: N. V. Makashova, et al.
Published: (2020-04-01)

Association of cardiorespiratory fitness with phenotypic age in younger population: a study based on the NHANES database
by: Yi Shen, et al.
Published: (2025-07-01)

Craniofacial parameters and obstructive sleep apnea in newly diagnosed acromegaly
by: Magdalena Pilarska, et al.
Published: (2025-07-01)

Selinexor combination with decitabine and half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with refractory/relapsed acute myeloid leukemia (AML) previously exposed to Venetoclax: a single-center retrospective study
by: Zi-Yu Zhao, et al.
Published: (2025-01-01)

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
by: Meira Yisraeli Salman, et al.
Published: (2025-07-01)

The Evolutionary History of CBF Transcription Factors: Gene Duplication of CCAAT – Binding Factors NF-Y in Plants
by: Cagliari, Alexandro, et al.
Published: (2011)

Bone Marrow Microenvironment in the Pathogenesis of AML
by: Blau, Olga
Published: (2011)

Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]
by: Zeidan AM, et al.
Published: (2025-07-01)

High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials.
by: Qiang Gong, et al.
Published: (2015-01-01)

Fundamentals of a personalized approach at different stages of newly diagnosed glaucoma
by: S. А. Zubasheva, et al.
Published: (2024-07-01)

Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment
by: Oudai Alkabbani, et al.
Published: (2025-07-01)

Stay younger longer
by: Meredith, Bronwen
Published: (1984)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)

WHICH IS THE BEST TREATMENT FOR AML WITH RESTRICTED RESOURCES
by: Mipsang Lama
Published: (2025-07-01)

Sex differences in skin microvascular structure and function in persons with newly diagnosed hypertension
by: A. A. Fedorovich, et al.
Published: (2023-10-01)

Newly diagnosed patent foramen ovale in an elderly patient: a case report
by: O. V. Soldatova, et al.
Published: (2025-04-01)

METABOLIC AND HEMOSTATIC PARAMETERS IN PRE-DIABETES AND NEWLY DIAGNOSED TYPE 2 DIABETES
by: G. G. Petrik, et al.
Published: (2016-04-01)

Clinical Study on Modified Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
by: Kawabata, Shinji, et al.
Published: (2011)

CLINICAL AND LABORATORY CHARACTERISTICS HIV-INFECTED PATIENTS WITH NEWLY DIAGNOSED KAPOSI’S SARCOMA
by: V. D. Renev, et al.
Published: (2019-03-01)

The condition of homeostatic equilibrium in patients with newly diagnosed pulmonary tuberculosis before treatment
by: N. A. Brazhenko, et al.
Published: (2014-12-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

CLINICAL AND SOCIAL CHARACTERISTICS OF PENAL INSTITUTIONS INMATES WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS
by: N. M. Koretskaya, et al.
Published: (2017-07-01)

The effect of immunomodulator azoximer bromide on immunoglobulin levels in children with newly diagnosed tuberculosis
by: O. M. Raznatovska, et al.
Published: (2022-08-01)

Prognostic Factors in Newly Diagnosed High‐Grade Osteosarcoma—A Systematic Review
by: Elisa Tirtei, et al.
Published: (2025-07-01)

Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV Infection
by: Yu. V. Ostankova, et al.
Published: (2020-10-01)

Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: results of «Novartis research»
by: article Editorial
Published: (2022-11-01)

DIAGNOSTICS, CLINICAL COURSE AND EFFECTIVENESS OF TREATMENT OF NEWLY DIAGNOSED YOUNG PATIENTS WITH RESPIRATORY TUBERCULOSIS
by: I. A. Morozov, et al.
Published: (2017-04-01)

Real-world characteristics and treatment patterns in Chinese patients with newly diagnosed endometrial cancer
by: Aijun Yin, et al.
Published: (2025-07-01)

Sex Differences in Newly Diagnosed Severe Aortic Stenosis in British Columbia (B.C.)
by: Aishwarya Roshan, et al.
Published: (2025-06-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01)